What Are Peptides?

Peptides are short chains of amino acids that can function as signaling molecules throughout the body.

Different peptides participate in different biological processes, including:

• Inflammatory signaling

• Angiogenesis

• Cell migration

• Collagen synthesis

• Extracellular matrix remodeling

• Tissue repair

• Bone metabolism

Because these same processes are essential to healing after oral surgery, there is increasing scientific and clinical interest in whether specific peptides may eventually have applications in dentistry and regenerative medicine.

Three peptides frequently discussed in the regenerative medicine literature are BPC-157, thymosin beta-4/TB-500, and GHK-Cu. It is important to distinguish between mechanistic or preclinical research and proven human dental treatments.

BPC-157

BPC-157 is a synthetic 15-amino-acid peptide derived from a sequence associated with a protective gastric protein.

Most of the research involving BPC-157 is preclinical.

Animal and laboratory studies have investigated its effects on:

• Angiogenesis

• Inflammation

• Tendon and ligament healing

• Gastrointestinal tissue repair

• Bone healing

• Fibroblast activity

• Vascular signaling

BPC-157 and Periodontal Research

BPC-157 is particularly interesting to dentistry because it has been investigated in experimental periodontal disease.

An animal study evaluating experimentally induced periodontitis examined the effect of BPC-157 on gingival inflammation and alveolar bone destruction.

This provides a biological basis for further research, but it does not establish BPC-157 as a treatment for periodontal disease in humans.

There is currently insufficient high-quality human clinical evidence to establish that BPC-157 improves:

• Extraction healing

• Implant osseointegration

• Bone graft incorporation

• Periodontal regeneration

• Oral surgical wound healing

These remain areas of scientific interest rather than established dental indications.

Thymosin Beta-4 and TB-500

Thymosin beta-4 is a naturally occurring peptide found in many tissues.

It has been studied for its role in:

• Cell migration

• Angiogenesis

• Actin regulation

• Inflammatory response

• Tissue repair

• Wound healing

Thymosin beta-4 has experimental wound-healing literature demonstrating biological activity related to tissue repair.

Is TB-500 the Same as Thymosin Beta-4?

Not exactly.

The names are frequently used interchangeably online, but TB-500 generally refers to a synthetic peptide associated with a region/fragment of thymosin beta-4.

Evidence involving the complete endogenous thymosin beta-4 molecule should therefore not automatically be assumed to apply directly to commercially marketed TB-500 products.

This distinction is important when evaluating peptide research.

GHK-Cu

GHK-Cu is a naturally occurring copper-binding tripeptide.

GHK stands for:

Glycine-Histidine-Lysine

When bound to copper, it forms the GHK-Cu complex.

GHK-Cu has been investigated primarily in skin and wound-healing research.

Proposed and observed biological activities in experimental research include:

• Collagen synthesis

• Extracellular matrix remodeling

• Angiogenesis

• Fibroblast activity

• Antioxidant activity

• Modulation of inflammatory signaling

• Tissue repair

These mechanisms are relevant to dentistry because collagen formation, vascularization, fibroblast activity, and extracellular matrix remodeling are essential components of gingival and surgical wound healing.

However, dental-specific human clinical evidence remains limited.

Why Peptides Are Interesting in Oral Surgery

Oral wound healing occurs through overlapping biological phases.

Hemostasis: A blood clot forms immediately following surgery and provides the initial wound matrix.

Inflammation: Immune cells migrate into the area and begin removing bacteria and damaged tissue while coordinating the repair response.

Proliferation: Fibroblasts, endothelial cells, and other cells begin forming new tissue. Angiogenesis establishes blood supply, and collagen begins forming the extracellular matrix.

Remodeling: Collagen reorganizes and matures while bone and soft tissues continue remodeling over weeks to months.

Because BPC-157, thymosin beta-4-related compounds, and GHK-Cu have been studied in pathways involved in these processes, researchers are interested in their potential regenerative applications.

Potential Areas of Dental Research

Peptide research may eventually have relevance to:

• Extraction socket healing

• Periodontal surgery

• Gingival wound healing

• Connective tissue grafting

• Bone grafting

• Implant surgery

• Alveolar bone regeneration

• Oral mucosal wounds

• Postoperative inflammation

At present, these should generally be viewed as potential or investigational applications, depending on the specific peptide and intended use.

Peptides and Dental Implants

Successful implant healing requires several biological processes:

• Adequate vascular supply

• Controlled inflammatory response

• Bone formation

• Bone remodeling

• Stable soft-tissue healing

• Osseointegration

For this reason, peptides affecting angiogenesis, inflammatory signaling, collagen metabolism, or bone biology are scientifically interesting in implant dentistry.

However, there is currently inadequate human clinical evidence to claim that BPC-157, TB-500, or GHK-Cu improves dental implant osseointegration.

Peptides and Periodontal Healing

Periodontal regeneration is particularly complex because treatment may involve:

• Gingiva

• Periodontal ligament

• Cementum

• Alveolar bone

• Blood supply

• Oral microbiome

A substance that improves one component of wound healing does not necessarily regenerate the complete periodontal attachment apparatus.This is why promising cellular or animal data must be followed by controlled human clinical studies.

Peptides vs. PRF

Peptide therapy should not be confused with Platelet-Rich Fibrin (PRF). PRF is an autologous blood concentrate made directly from the patient's own blood. After centrifugation, PRF provides a fibrin matrix containing platelets, leukocytes, and naturally occurring signaling molecules.

At Amore Dentistry, PRF can be incorporated directly into appropriate surgical procedures such as:

• Extractions

• Bone grafting

• Implant placement

• Periodontal surgery

• Other regenerative procedures

Peptides are different. They are individual molecular compounds intended to influence specific biological pathways.

The evidence base and regulatory status of each peptide must therefore be considered independently.

Where Peptides Fit Into Biologic Dentistry

Biologic oral surgery begins with the fundamentals:

• Thorough diagnosis

• Removal of infection and diseased tissue

• Atraumatic surgical technique

• Preservation of blood supply

• Appropriate debridement

• Stable clot formation

• Appropriate graft selection when necessary

• PRF when indicated

• Primary or appropriate wound closure

• Nutrition and postoperative care

• Management of systemic factors affecting healing

No peptide replaces these principles.

The scientific question is whether peptide-based therapies may eventually provide an adjunct capable of modifying particular components of the healing response.

Current Regulatory and Evidence Status

BPC-157 and TB-500 are not currently FDA-approved drugs for dental wound healing, periodontal regeneration, implant osseointegration, or bone regeneration.

Research involving these compounds remains limited, particularly in humans.

GHK-Cu also should not be represented as an established treatment for dental surgical healing based solely on research performed in skin or other tissues.

Patients should understand the difference between:

Preclinical research, Human clinical research, FDA approval, Pharmacy compounding, and Established dental standard of care  - these terms do not mean the same thing.

Our interest in peptide science is based on its potential relationship with regenerative biology—not on presenting experimental therapies as established treatments.

Our Approach to Regenerative Dentistry

We continue to follow emerging research involving peptides, growth factors, PRF, biomaterials, bone regeneration, wound healing, and tissue engineering.

As evidence develops, our goal is to evaluate these therapies based on:

• Biological mechanism

• Published evidence

• Human safety data

• Clinical efficacy

• Product quality

• Regulatory status

• Relevance to oral tissues

Regenerative dentistry is rapidly evolving, but new treatments should be incorporated based on evidence rather than popularity.

The information on this page is provided for education and discussion of emerging research. It does not represent BPC-157, TB-500, or GHK-Cu as FDA-approved treatments for dental disease or surgical healing